Refine
Year of publication
- 2018 (92) (remove)
Document Type
- Article (47)
- Postprint (15)
- Other (13)
- Review (11)
- Doctoral Thesis (6)
Is part of the Bibliography
- yes (92) (remove)
Keywords
- Chronic back pain (3)
- Prognosis (3)
- athletic performance (3)
- exercise movement techniques (3)
- gait (3)
- inflammation (3)
- music (3)
- music therapy (3)
- prevention (3)
- stroke rehabilitation (3)
Institute
- Department Sport- und Gesundheitswissenschaften (92) (remove)
Die Mehrzahl der Schlaganfallpatienten leidet unter Störungen der Gehfähigkeit. Die Behandlung der Folgen des Schlaganfalls stellt eine der häufigsten Indikationen für die neurologische Rehabilitation dar. Dabei steht die Wiederherstellung von sensomotorischen Funktionen, insbesondere der Gehfähigkeit, und der gesellschaftlichen Teilhabe im Vordergrund.
In Deutschland wird in der Gangrehabilitation nach Schlaganfall oft das Neurophysiologische Gangtraining nach Bobath (NGB) angewandt, das jedoch in seiner Effektivität kritisch gesehen wird. In Behandlungsleitlinien wird zuerst das Laufbandtraining (LT) empfohlen. Für diese Therapie liegen Wirknachweise für Verbesserungen in Gehgeschwindigkeit und Gehausdauer vor. Auch für die Rhythmisch-auditive Stimulation (RAS), dem ebenerdigen Gangtraining mit akustischer Stimulation liegt vergleichbare Evidenz für Schlaganfallpatienten vor.
Ziel der durchgeführten Studie war es, zu klären ob der Einsatz von RAS die Effektivität von LT verbessert. Es wurden die Auswirkungen eines 4-wöchigen musikgestützten Laufbandtrainings auf die Gangrehabilitation von Schlaganfallpatienten untersucht.
Für die Kombinationstherapie RAS mit Laufbandtraining (RAS-LT) wurde spezielle Trainingsmusik entwickelt. Diese wurde an die individuelle Laufbandkadenz des Patienten angepasst und in Abstimmung mit der Bandgeschwindigkeit systematisch gesteigert. Untersucht wurde, ob RAS-LT zu stärkeren Verbesserungen der Gehfähigkeit bei Schlaganfallpatienten führt als die Standardtherapien NGB und LT. Dazu wurde eine klinische Evaluation im prospektiven randomisierten und kontrollierten Parallelgruppendesign mit 45 Patienten nach Schlaganfall durchgeführt. 45 Patienten mit Hemiparese der unteren Extremität oder unsicherem und asymmetrischem Gangbild wurden in der Akutphase nach Schlaganfall eingeschlossen. Bei 10 Patienten wurde die Studie während der Interventionsphase abgebrochen, davon 1 Patient mit unerwünschter Nebenwirkung in Folge des LT.
Die verwendete Testbatterie umfasste neben Verfahren zur Bestimmung der Gehfunktion wie Fast Gait Speed Test, 3-min-Walking-Time-Test und der apparativen Ganganalyse mit dem Lokometer nach Bessou eine statische Posturographie und eine kinematische 2D-Ganganalyse auf dem Laufband. Diese Methode wurde in Erweiterung der bisherigen Studienlage in dieser Form erstmals für diese Fragestellung und dieses Patientenkollektiv konzipiert und eingesetzt. Sie ermöglichte eine differenzierte und seitenbezogene Beurteilung der Bewegungsqualität.
Die primären Endpunkte der Studie waren die longitudinalen Gangparameter Kadenz, Gehgeschwindigkeit und Schrittlänge. Als sekundäre Endpunkte dienten die Schrittsymmetrie, die Gehausdauer, das statische Gleichgewicht und die Bewegungsqualität des Gehens.
Prä-Post-Effekte wurden für die gesamte Stichprobe und für jede Gruppe durch T-Tests und wenn Normalverteilung nicht gegeben war mit dem Wilcoxon-Vorzeichen-Rangtest errechnet. Für die Ermittlung der Wirkungsunterschiede der 3 Interventionen wurde eine Kovarianzanalyse mit zwei Kovariaten durchgeführt: (1) der jeweilige Prä-Interventionsparameter und (2) die Zeit zwischen Akutereignis und Studienbeginn. Für einzelne Messparameter waren die Vorbedingungen der Kovarianzanalyse nicht erfüllt, sodass stattdessen ein Kruskal-Wallis H Test durchgeführt wurde. Das Signifikanzniveau wurde auf p < 0,05 und für gruppenspezifische Prä-Post-Effekte auf p > 0,016 gesetzt. Effektstärken wurden mit Cohens d berechnet.
Es wurden die Datensätze von 35 Patienten (RAS-LT: N = 11, LT: N = 13, NGB: N = 11) mit einem Alter von 63.6 ±8.6 Jahren, und mit einer Zeit zwischen Akutereignis und Beginn der Studie von 42.1 ±23.7 Tagen ausgewertet. In der statistischen Auswertung zeigten sich in der Nachuntersuchung stärkere Verbesserungen durch RAS-LT in der Kadenz (F(2,34) = 7.656, p = 0.002; partielles η2 = 0.338), wobei auch die Gruppenkontraste signifikante Unterschiede zugunsten von RAS-LT aufwiesen und eine Tendenz zu stärkerer Verbesserung in der Gehgeschwindigkeit (F(2,34) = 3.864, p = 0.032; partielles η2 = 0.205). Auch die Ergebnisse zur Schrittsymmetrie und zur Bewegungsqualität deuteten auf eine Überlegenheit des neuen Therapieansatzes RAS-LT hin, obgleich dort keine statistischen Signifikanzen im Gruppenvergleich erreicht wurden. Die Parameter Schrittlänge, Gehausdauer und die Werte zum statischen Gleichgewicht zeigten keine spezifischen Effekte von RAS-LT.
Die Studie liefert erstmals Anhaltspunkte für eine klinische Überlegenheit von RAS-LT gegenüber den Standardtherapien. Die weitere Entwicklung und Beforschung dieses innovativen Therapieansatzes können in Zukunft zu einer verbesserten Gangrehabilitation von Patienten nach Schlaganfall beitragen.
Vitamin D, either in its D-2 or D-3 form, is essential for normal human development during intrauterine life, kidney function and bone health. Vitamin D deficiency has also been linked to cancer development and some auto immune diseases. Given this huge impact of vitamin Don human health, it is important for daily clinical practice and clinical research to have reliable tools to judge on the vitamin D status. The major circulating form of vitamin D is 25-hydroxyvitamin D (25(OH)D), although it is not the most active metabolite, the concentrations of total 25-hydroxyvitamin D in the serum are currently routinely used in clinical practice to assess vitamin D status. In the circulation, vitamin D - like other steroid hormones - is bound tightly to a special carrier - vitamin D-binding protein (DBP). Smaller amounts are bound to blood proteins - albumin and lipoproteins. Only very tiny amounts of the total vitamin D are free and potentially biologically active. Currently used vitamin D assays do not distinguish between the three forms of vitamin D - DBP-bound vitamin D, albumin-bound vitamin D and free, biologically active vitamin D. Diseases or conditions that affect the synthesis of DBP or albumin thus have a huge impact on the amount of circulating total vitamin D. DBP and albumin are synthesized in the liver, hence all patients with an impairment of liver function have alterations in their total vitamin D blood concentrations, while free vitamin D levels remain mostly constant. Sex steroids, in particular estrogens, stimulate the synthesis of DBP. This explains why total vitamin D concentrations are higher during pregnancy as compared to nonpregnant women, while the concentrations of free vitamin D remain similar in both groups of women. The vitamin D-DBP as well as vitamin D-albumin complexes are filtered through the glomeruli and re-uptaken by megalin in the proximal tubule. Therefore, all acute and chronic kidney diseases that are characterized by a tubular damage, are associated with a loss of vitamin D-DBP complexes in the urine. Finally, the gene encoding DBP protein is highly polymorphic in different human racial groups. In the current review, we will discuss how liver function, estrogens, kidney function and the genetic background might influence total circulating vitamin D levels and will discuss what vitamin D metabolite is more appropriate to measure under these conditions: free vitamin D or total vitamin D.
Our experimental approach included two studies to determine discriminative validity and test-retest reliability (study 1) as well as ecological validity (study 2) of a judo ergometer system while performing judo-specific movements. Sixteen elite (age: 23 +/- 3 years) and 11 sub-elite (age: 16 +/- 1 years) athletes participated in study 1 and 14 male sub-elite judo athletes participated in study 2. Discriminative validity and test-retest reliability of sport-specific parameters (mechanical work, maximal force) were assessed during pulling movements with and without tsukuri (kuzushi). Ecological validity of muscle activity was determined by performing pulling movements using the ergometer without tsukuri and during the same movements against an opponent. In both conditions, electromyographic activity of trunk (e.g., m. erector spinae) and upper limb muscles (e.g., m. biceps brachii) were assessed separately for the lifting and pulling arm. Elite athletes showed mostly better mechanical work, maximal force, and power (0.12 <= d <= 1.80) compared with sub-elite athletes. The receiver operating characteristic analysis revealed acceptable validity of the JERGo(C) system to discriminate athletes of different performance levels predominantly during kuzushi without tsukuri (area under the curve = 0.27-0.90). Moreover, small-to-medium discriminative validity was found to detect meaningful performance changes for mechanical work and maximal force. The JERGo(C) system showed small-to-high relative (ICC = 0.37-0.92) and absolute reliability (SEM = 10.8-18.8%). Finally, our analyses revealed acceptable correlations (r = 0.41-0.88) between muscle activity during kuzushi performed with the JERGo(C) system compared with a judo opponent. Our findings indicate that the JERGo(C) system is a valid and reliable test instrument for the assessment and training of judo-specific pulling kinetics particularly during kuzushi movement without tsukuri.
Introduction:
We aim to highlight the utility of this model in the analysis of the psycho-behavioral implications of family cancer, presenting the scientific literature that used Leventhal’s model as the theoretical framework of approach.
Material and methods:
A systematic search was performed in six databases (EBSCO, ScienceDirect, PubMed Central, ProQuest, Scopus, and Web of Science) with empirical studies published between 2006 and 2015 in English with regard to the Common Sense Model of Self-Regulation (CSMR) and familial/hereditary cancer. The key words used were: illness representations, common sense model, self regulatory model, familial/hereditary/genetic cancer, genetic cancer counseling. The selection of studies followed the PRISMA-P guidelines (Moher et al., 2009; Shamseer et al., 2015), which suggest a three-stage procedure.
Results:
Individuals create their own cognitive and emotional representation of the disease when their health is threatened, being influenced by the presence of a family history of cancer, causing them to adopt or not a salutogenetic behavior. Disease representations, particularly the cognitive ones, can be predictors of responses to health threats that determine different health behaviors. Age, family history of cancer, and worrying about the disease are factors associated with undergoing screening. No consensus has been reached as to which factors act as predictors of compliance with cancer screening programs.
Conclusions:
This model can generate interventions that are conceptually clear as well as useful in regulating the individuals’ behaviors by reducing the risk of developing the disease and by managing as favorably as possible health and/or disease.
The use of functional music in gait training termed rhythmic auditory stimulation (RAS) and treadmill training (TT) have both been shown to be effective in stroke patients (SP). The combination of RAS and treadmill training (RAS-TT) has not been clinically evaluated to date. The aim of the study was to evaluate the efficacy of RAS-TT on functional gait in SR The protocol followed the design of an explorative study with a rater-blinded three arm prospective randomized controlled parallel group design. Forty-five independently walking SP with a hemiparesis of the lower limb or an unsafe and asymmetrical walking pattern were recruited. RAS-TT was carried out over 4 weeks with TT and neurodevelopmental treatment based on Bobath approach (NDT) serving as control interventions. For RAS-TT functional music was adjusted individually while walking on the treadmill. Pre and post-assessments consisted of the fast gait speed test (FGS), a gait analysis with the locometre (LOC), 3 min walking time test (3MWT), and an instrumental evaluation of balance (IEB). Raters were blinded to group assignments. An analysis of covariance (ANCOVA) was performed with affiliated measures from pre-assessment and time between stroke and start of study as covariates. Thirty-five participants (mean age 63.6 +/- 8.6 years, mean time between stroke and start of study 42.1 +/- 23.7 days) completed the study (11 RAS-TT, 13 TT, 11 NDT). Significant group differences occurred in the FGS for adjusted post-measures in gait velocity [F-(2,F- (34)) = 3.864, p = 0.032; partial eta(2) = 0.205] and cadence [F-(2,F- 34) = 7.656, p = 0.002; partial eta(2) = 0.338]. Group contrasts showed significantly higher values for RAS-TT. Stride length results did not vary between the groups. LOC, 3MWT, and IEB did not indicate group differences. One patient was withdrawn from TT because of pain in one arm. The study provides first evidence for a higher efficacy of RAS-TT in comparison to the standard approaches TT and NDT in restoring functional gait in SP. The results support the implementation of functional music in neurological gait rehabilitation and its use in combination with treadmill training.
The use of functional music in gait training termed rhythmic auditory stimulation (RAS) and treadmill training (TT) have both been shown to be effective in stroke patients (SP). The combination of RAS and treadmill training (RAS-TT) has not been clinically evaluated to date. The aim of the study was to evaluate the efficacy of RAS-TT on functional gait in SR The protocol followed the design of an explorative study with a rater-blinded three arm prospective randomized controlled parallel group design. Forty-five independently walking SP with a hemiparesis of the lower limb or an unsafe and asymmetrical walking pattern were recruited. RAS-TT was carried out over 4 weeks with TT and neurodevelopmental treatment based on Bobath approach (NDT) serving as control interventions. For RAS-TT functional music was adjusted individually while walking on the treadmill. Pre and post-assessments consisted of the fast gait speed test (FGS), a gait analysis with the locometre (LOC), 3 min walking time test (3MWT), and an instrumental evaluation of balance (IEB). Raters were blinded to group assignments. An analysis of covariance (ANCOVA) was performed with affiliated measures from pre-assessment and time between stroke and start of study as covariates. Thirty-five participants (mean age 63.6 +/- 8.6 years, mean time between stroke and start of study 42.1 +/- 23.7 days) completed the study (11 RAS-TT, 13 TT, 11 NDT). Significant group differences occurred in the FGS for adjusted post-measures in gait velocity [F-(2,F- (34)) = 3.864, p = 0.032; partial eta(2) = 0.205] and cadence [F-(2,F- 34) = 7.656, p = 0.002; partial eta(2) = 0.338]. Group contrasts showed significantly higher values for RAS-TT. Stride length results did not vary between the groups. LOC, 3MWT, and IEB did not indicate group differences. One patient was withdrawn from TT because of pain in one arm. The study provides first evidence for a higher efficacy of RAS-TT in comparison to the standard approaches TT and NDT in restoring functional gait in SP. The results support the implementation of functional music in neurological gait rehabilitation and its use in combination with treadmill training.
Serious knee pain and related disability have an annual prevalence of approximately 25% on those over the age of 55 years. As curative treatments for the common knee problems are not available to date, knee pathologies typically progress and often lead to osteoarthritis (OA). While the roles that the meniscus plays in knee biomechanics are well characterized, biological mechanisms underlying meniscus pathophysiology and roles in knee pain and OA progression are not fully clear. Experimental treatments for knee disorders that are successful in animal models often produce unsatisfactory results in humans due to species differences or the inability to fully replicate disease progression in experimental animals. The use of animals with spontaneous knee pathologies, such as dogs, can significantly help addressing this issue. As microscopic and macroscopic anatomy of the canine and human menisci are similar, spontaneous meniscal pathologies in canine patients are thought to be highly relevant for translational medicine. However, it is not clear whether the biomolecular mechanisms of pain, degradation of extracellular matrix, and inflammatory responses are species dependent. The aims of this review are (1) to provide an overview of the anatomy, physiology, and pathology of the human and canine meniscus, (2) to compare the known signaling pathways involved in spontaneous meniscus pathology between both species, and (3) to assess the relevance of dogs with spontaneous meniscal pathology as a translational model. Understanding these mechanisms in human and canine meniscus can help to advance diagnostic and therapeutic strategies for painful knee disorders and improve clinical decision making.
Serious knee pain and related disability have an annual prevalence of approximately 25% on those over the age of 55 years. As curative treatments for the common knee problems are not available to date, knee pathologies typically progress and often lead to osteoarthritis (OA). While the roles that the meniscus plays in knee biomechanics are well characterized, biological mechanisms underlying meniscus pathophysiology and roles in knee pain and OA progression are not fully clear. Experimental treatments for knee disorders that are successful in animal models often produce unsatisfactory results in humans due to species differences or the inability to fully replicate disease progression in experimental animals. The use of animals with spontaneous knee pathologies, such as dogs, can significantly help addressing this issue. As microscopic and macroscopic anatomy of the canine and human menisci are similar, spontaneous meniscal pathologies in canine patients are thought to be highly relevant for translational medicine. However, it is not clear whether the biomolecular mechanisms of pain, degradation of extracellular matrix, and inflammatory responses are species dependent. The aims of this review are (1) to provide an overview of the anatomy, physiology, and pathology of the human and canine meniscus, (2) to compare the known signaling pathways involved in spontaneous meniscus pathology between both species, and (3) to assess the relevance of dogs with spontaneous meniscal pathology as a translational model. Understanding these mechanisms in human and canine meniscus can help to advance diagnostic and therapeutic strategies for painful knee disorders and improve clinical decision making.